Neogen Corporation Launches Reveal® Q+ for Aflatoxin M1
January 12, 2021 at 08:45 am EST
Share
Neogen Corporation announced that it has launched a quicker, easier test to detect aflatoxin M1, a known cancer-causing toxin of concern to the global dairy industry. Neogen's new Reveal® Q+ for Aflatoxin M1 can detect as little as 150 parts per trillion (ppt) of the toxin in milk samples in just minutes. The new test is designed for use with Neogen's Raptor® Integrated Analysis Platform, which controls the timing, temperature and reading of the test strips — allowing testers to simply add sample and walk away. Aflatoxin M1 is a carcinogenic metabolite of aflatoxin B1 that is produced in the rumen of dairy cattle. Many countries, including the United States and Brazil, have a regulatory limit of 500 ppt for aflatoxin M1. The new test can detect aflatoxin M1 in milk within a range of 150 to 600 ppt. Reveal Q+ for Aflatoxin M1 utilizes the same incubation temperature and time as Neogen's BetaStar® antibiotic tests, including tests for beta-lactams (e.g., amoxicillin, ampicillin and penicillin) and tetracyclines. The Raptor platform automatically incubates and analyzes up to three milk samples independently and simultaneously. The system also protects the integrity and consistency of testing data by processing and analyzing results without additional operator input. Neogen offers the most comprehensive range of food safety diagnostic test products for foodborne bacteria, mycotoxins, dairy antibiotics, food allergens, and other concerns. Its full line of mycotoxin test kits detect aflatoxin, deoxynivalenol (DON), fumonisin, ochratoxin, T-2/HT-2, and zearalenone.
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
NEOGEN CORPORATION 
